Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Diseases

  Free Subscription


1 Am J Gastroenterol
1 Am J Pathol
1 Ann Intern Med
2 Anticancer Res
2 Biochem Biophys Res Commun
2 BMC Cancer
1 Cancer
1 Dig Dis Sci
4 Hepatology
1 J Gastroenterol
2 J Gastroenterol Hepatol
3 J Hepatol
2 N Engl J Med
2 PLoS Comput Biol
2 Radiology
9 Transplant Proc

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Gastroenterol

  1. FARUQUI S, Okoli FC, Olsen SK, Feldman DM, et al
    Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
    Am J Gastroenterol. 2021 May 17. pii: 00000434-900000000-98779.
    PubMed         Abstract available

    Am J Pathol

  2. MATTHEWS DR, Li H, Zhou J, Li Q, et al
    Methionine- and Choline-deficient Diet-induced Non-alcoholic Steatohepatitis Is Associated with Increased Intestinal Inflammation.
    Am J Pathol. 2021 Jul 6. pii: S0002-9440(21)00302.
    PubMed         Abstract available

    Ann Intern Med

    In patients having transjugular intrahepatic portosystemic shunt, rifaximin prevented overt hepatic encephalopathy.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/ACPJ202107200.
    PubMed         Abstract available

    Anticancer Res

  4. KUBO H, Ikoma H, Yamamoto Y, Morimura R, et al
    Therapeutic Strategy of Colorectal Liver Metastasis Using Modified-JHBPS Nomogram.
    Anticancer Res. 2021;41:3657-3665.
    PubMed         Abstract available

  5. VIEIRA JF, Peixoto AP, Murta EFC, Michelin MA, et al
    Prophylactic Dendritic Cell Vaccination in Experimental Breast Cancer Controls Immunity and Hepatic Metastases.
    Anticancer Res. 2021;41:3419-3427.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  6. PHO-IAM T, Punnakitikashem P, Somboonyosdech C, Sripinitchai S, et al
    PLGA nanoparticles containing alpha-fetoprotein siRNA induce apoptosis and enhance the cytotoxic effects of doxorubicin in human liver cancer cell line.
    Biochem Biophys Res Commun. 2021;553:191-197.
    PubMed         Abstract available

  7. LEILEI L, Xue S, Yan L, Yuyuan L, et al
    PM2.5-exposed hepatocytes induce hepatic stellate cells activation by releasing TGF-beta1.
    Biochem Biophys Res Commun. 2021;569:125-131.
    PubMed         Abstract available

    BMC Cancer

  8. GAO X, Zhao C, Zhang N, Cui X, et al
    Genetic expression and mutational profile analysis in different pathologic stages of hepatocellular carcinoma patients.
    BMC Cancer. 2021;21:786.
    PubMed         Abstract available

  9. YANG MY, Wu F, Fang F, Yang H, et al
    Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma.
    BMC Cancer. 2021;21:772.
    PubMed         Abstract available


  10. DING X, Sun W, Li W, Shen Y, et al
    Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
    Cancer. 2021 Jul 8. doi: 10.1002/cncr.33677.
    PubMed         Abstract available

    Dig Dis Sci

  11. LIU J, He X, Zou Y, Wang K, et al
    Circular RNA Circ-STIL Contributes to Cell Growth and Metastasis in Hepatocellular Carcinoma via Regulating miR-345-5p/AQP3 Axis.
    Dig Dis Sci. 2021 Jul 6. pii: 10.1007/s10620-021-07054.
    PubMed         Abstract available


  12. ZHENG J, Daniel CR, Hatia RI, Stuff J, et al
    Dietary N-Nitroso Compounds and Risk of Hepatocellular Carcinoma: A US-Based Study.
    Hepatology. 2021 Jul 7. doi: 10.1002/hep.32046.
    PubMed         Abstract available

  13. LAI JC, Tandon P, Bernal W, Tapper EB, et al
    Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2021 Jul 7. doi: 10.1002/hep.32049.
    PubMed         Abstract available

  14. KIM OK, Nam DE, Hahn YS
    The Panx1/P2X4 pathway controls the secretion of miRNA-containing exosomes by HCV-infected hepatocytes.
    Hepatology. 2021 Jul 4. doi: 10.1002/hep.32042.
    PubMed         Abstract available

  15. CAPORALI C, Turco L, Prampolini F, Quaretti P, et al
    Proximal splenic artery embolization to treat refractory ascites in a cirrhotic patient.
    Hepatology. 2021 Jul 4. doi: 10.1002/hep.32037.
    PubMed         Abstract available

    J Gastroenterol

  16. YOSHIJI H, Nagoshi S, Akahane T, Asaoka Y, et al
    Evidence-based clinical practice guidelines for Liver Cirrhosis 2020.
    J Gastroenterol. 2021 Jul 7. pii: 10.1007/s00535-021-01788.
    PubMed         Abstract available

    J Gastroenterol Hepatol

  17. LUM JHM, Cheah MCC, Leow WQ, Wan WK, et al
    Clinical profile of non-alcoholic fatty liver disease in nonobese patients.
    J Gastroenterol Hepatol. 2021;36:257-261.
    PubMed         Abstract available

  18. GRONBAEK H, Moller HJ, Saliba F, Zeuzem S, et al
    Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.
    J Gastroenterol Hepatol. 2021;36:240-248.
    PubMed         Abstract available

    J Hepatol

  19. ALVARADO-TAPIAS E, Vilades D, Brujats A, Villanueva C, et al
    Reply letter to correspondence entitled: "Non-selective beta blockers and mortality in decompensated Cirrhosis: Is Cirrhotic Cardiomyopathy the missing link?"
    J Hepatol. 2021 Jul 2. pii: S0168-8278(21)01846.

  20. SLADKY VC, Eichin F, Reiberger T, Villunger A, et al
    Polyploidy control in hepatic health and disease.
    J Hepatol. 2021 Jul 3. pii: S0168-8278(21)01879.
    PubMed         Abstract available

  21. ZHU C, Boucheron N, Muller AC, Majek P, et al
    24-NorUrsodeoxycholic acid reshapes immunometabolism in CD8(+) T-cells and alleviates hepatic inflammation.
    J Hepatol. 2021 Jul 6. pii: S0168-8278(21)01886.
    PubMed         Abstract available

    N Engl J Med

  22. NEWSOME PN, Sejling AS, Sanyal AJ
    Semaglutide or Placebo for Nonalcoholic Steatohepatitis. Reply.
    N Engl J Med. 2021;385:e6.

  23. DA BL, Satapathy SK
    Semaglutide or Placebo for Nonalcoholic Steatohepatitis.
    N Engl J Med. 2021;385:e6.

    PLoS Comput Biol

  24. LIM HC, Gordan JD
    Tumor hepatitis B virus RNA identifies a clinically and molecularly distinct subset of hepatocellular carcinoma.
    PLoS Comput Biol. 2021;17:e1008699.
    PubMed         Abstract available

  25. YU L, Wang M, Yang Y, Xu F, et al
    Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways.
    PLoS Comput Biol. 2021;17:e1008696.
    PubMed         Abstract available


  26. KRINSKY G, Shanbhogue K
    Proliferative versus Nonproliferative Hepatocellular Carcinoma: Clinical and Imaging Implications.
    Radiology. 2021 Jul 6:211316. doi: 10.1148/radiol.2021211316.

  27. KANG HJ, Kim H, Lee DH, Hur BY, et al
    Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
    Radiology. 2021 Jul 6:204352. doi: 10.1148/radiol.2021204352.
    PubMed         Abstract available

    Transplant Proc

  28. STOLL WD, Mester RA, Fleming JN, Sirianni JM, et al
    Impact of Anesthesiologist Experience on Early Outcomes in Adult Orthotopic Liver Transplantation.
    Transplant Proc. 2021 May 18. pii: S0041-1345(21)00251.
    PubMed         Abstract available

  29. TAKAMATSU FY, Gonzalez AM, Sa GP, Salzedas-Netto AA, et al
    Transplantation in Hepatocellular Carcinoma: Observational Multivariate Analysis of Survival and Recurrence Factors in 414 Patients.
    Transplant Proc. 2021 Jul 3. pii: S0041-1345(21)00407.
    PubMed         Abstract available

  30. LEE JE, Jung H, Cho JD, Choi EK, et al
    The Role of Dexmedetomidine in Hepatic Ischemia-Reperfusion Injury Via a Nitric Oxide-Dependent Mechanism in Rats.
    Transplant Proc. 2021 Jul 6. pii: S0041-1345(21)00425.
    PubMed         Abstract available

  31. DALE M, Sogawa H, Seyedsaadat SM, Wolf DC, et al
    Successful Management of COVID-19 Infection in 2 Early Post-Liver Transplant Recipients.
    Transplant Proc. 2021 Mar 19. pii: S0041-1345(21)00198.
    PubMed         Abstract available

  32. ALVIKAS J, Deeb AP, Jorgensen DR, Minervini MI, et al
    Moderately Macrosteatotic Livers Have Acceptable Long-Term Outcomes but Higher Risk of Immediate Mortality.
    Transplant Proc. 2021;53:1682-1689.
    PubMed         Abstract available

  33. MAVROUDI A, Imvrios G, Xinias I, Cassimos D, et al
    Tacrolimus Immunosuppression Causes Drug-Induced Hypersensitivity Reactions in Liver-Transplant Patients: A 3-Case Report.
    Transplant Proc. 2021 May 4. pii: S0041-1345(21)00224.
    PubMed         Abstract available

  34. RENZO CD, D'Amico F, Finotti M, Vitale A, et al
    A Novel Entity Among Vascular Liver Tumors: The First Reported Liver Transplantation. Is It Feasible?
    Transplant Proc. 2021 May 14. pii: S0041-1345(21)00229.
    PubMed         Abstract available

  35. CHUNG H, Kim SH, Jo KW, Shim TS, et al
    Clinical Characteristics and Risk Factors of Early-Onset Tuberculosis After Liver Transplantation.
    Transplant Proc. 2021 May 17. pii: S0041-1345(21)00263.
    PubMed         Abstract available

  36. BHATTI S, Rashed H, Abell T
    Autonomic Nervous System Profiling In Response to Liver Transplantation: Prognostic Evaluation and Preliminary Study.
    Transplant Proc. 2021 May 13. pii: S0041-1345(21)00252.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.